UBS Group AG - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 43 filers reported holding OCUPHIRE PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q2 2023$37,979
+1695.7%
8,751
+1451.6%
0.00%
Q1 2023$2,115
-29.5%
564
-66.8%
0.00%
Q3 2022$3,000
-40.0%
1,700
-31.1%
0.00%
Q2 2022$5,000
-73.7%
2,466
-57.1%
0.00%
Q1 2022$19,000
-29.6%
5,748
-19.6%
0.00%
Q4 2021$27,000
-34.1%
7,145
-8.8%
0.00%
Q3 2021$41,000
+36.7%
7,838
+41.4%
0.00%
Q2 2021$30,000
+172.7%
5,542
+206.2%
0.00%
Q1 2021$11,0001,8100.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Regency Capital Management Inc.\DE 15,000$79,0000.06%
Ikarian Capital, LLC 119,551$632,0000.05%
NORRIS PERNE & FRENCH LLP/MI 78,909$417,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 23,445$124,0000.02%
Stokes Family Office, LLC 12,120$64,0000.01%
MARSHALL WACE, LLP 329,131$1,738,0000.01%
Cornerstone Capital, Inc. 11,357$60,0000.01%
MCF Advisors LLC 9,499$50,0000.01%
Cutler Group LLC / CA 7,900$41,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 13,389$71,0000.00%
View complete list of OCUPHIRE PHARMA INC shareholders